Drive Life Sciences

SCbio and MassBio Launch Drive Accelerator for Fall 2026 Cohorts

About Drive

Drive is an accelerator program designed to advance breakthrough science while providing opportunities to innovators from all parts of the life sciences ecosystem. Fueled initially by MassBio and SCbio, Drive is building an interconnected network of resources between ecosystems to support emerging companies. Twice a year, we support a small group of groundbreaking scientists by connecting them with business fundamentals curriculum, mentorship, industry connections and equity-free prizes, without taking anything in return.

Applications for Drive’s Fall 2026 cohort are closed.

How It Works

During each 8-week hybrid program, Drive startups receive:

  • Six industry-specific curriculum modules led by experts
  • Weekly sessions with a tailored team of mentors
  • Networking opportunities and industry connections throughout each cohort session, leading up to in-person Demo Days in Charleston and Boston
  • Drive participants will receive in-kind prizes from Premier Sponsors specific to SCbio and MassBio
Drive does not take any equity from the companies we support. Our program is free to all participants.

Applicant Qualifications

You’re eligible to apply for Drive if:

  • You have a high-potential therapeutic pipeline or platform with an asset, or you are using AI and/or machine learning in support of drug discovery and development. 
  • Your startup has access to the intellectual property for your science or technology, either through a license agreement or through an option agreement to negotiate a license agreement.
  • Your startup has raised less than $1.5 million in dilutive capital.
  • You will be able to participate in all cornerstone components of the program (curriculum, weekly mentoring sessions and networking events).

Applications for Drive's Fall 2026 cohort are closed.

Mentors

Mentors play a crucial role in the success of the Drive program, offering their expertise to guide and support the emerging startups participating in the program. By volunteering as a mentor, experienced professionals can have a lasting impact, contribute to the development of groundbreaking therapies and technology, and enrich their own careers through meaningful engagement with the biotech and techbio startup community. 

 
  • Impactful Contribution | Help startups take the first step.
  • Knowledge Sharing | Pass on insights and experiences to future biotech and techbio leaders.
  • Professional Development | Enhance leadership and communication skills while staying current with industry trends.
  • Networking | Connect with industry professionals, entrepreneurs, and investors for collaboration and opportunities.
  • Volunteer | Contribute to the biotech and/or techbio community by supporting the ecosystem that fostered their own success.

Fall 2026 Drive Partners - SCbio

Biotech Track Curriculum Experts

Drug Development

Fundraising

Intellectual Property & Legal

Marketing + Advertising

Regulatory

Biotech

Biotech Track Review Board

Biotech Track Premier Sponsors

Fall 2026 Drive Partners - MassBio

Sign Up For Accelerator Updates

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more.

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.